WMIC: Caliper bolsters product line
Caliper Life Sciences has introduced a series of XenoLight Rediject reagents for in vivo imaging systems at the 2009 World Molecular Imaging Congress (WMIC) in Montreal this week.
Rediject D-Luciferin Ultra is the latest in an expanding range of XenoLight reagents, according to the Hopkinton, Mass.-based firm. It is supplied in a ready-to-inject format, pre-formulated with a tracking agent in order to monitor injection quality and minimize data variability.
Using this reagent in an in vivo imaging system, researchers can validate their techniques and generate more reproducible data in less time, according to Caliper.
In the past year, the company has also introduced two imaging platforms, including the IVIS Kinetic, which uses video-rate imaging to image biological processes in real-time, and the IVIS Lumina XR, Caliper's first instrument to integrate fluorescence, bioluminescence and x-ray capabilities into a single system.
Rediject D-Luciferin Ultra is the latest in an expanding range of XenoLight reagents, according to the Hopkinton, Mass.-based firm. It is supplied in a ready-to-inject format, pre-formulated with a tracking agent in order to monitor injection quality and minimize data variability.
Using this reagent in an in vivo imaging system, researchers can validate their techniques and generate more reproducible data in less time, according to Caliper.
In the past year, the company has also introduced two imaging platforms, including the IVIS Kinetic, which uses video-rate imaging to image biological processes in real-time, and the IVIS Lumina XR, Caliper's first instrument to integrate fluorescence, bioluminescence and x-ray capabilities into a single system.